ABCC2 and metabolic dysfunction-associated steatohepatitis: Compared to WT-C mice, the concentration of SFB-G in the liver in WT-NASH mice decreased by 45%; compared to Mrp2−/−-C mice, SFB-G concentration in Mrp2–/–-NASH mice decreased by 85%.